The Oral
Cancer Diagnostics Market Share is anticipated to reach USD 2,729.72
Million by 2030 at 4.8% CAGR during the forecast period 2022-2030. Market
Research Future (MRFR) makes a claim that the growth would be pervasive and
attaining of this valuation would be easier.
Several factors like hike in awareness,
better diagnostic procedures, rise in per capita income, improved reimbursement
schemes, and others are expected to provide traction to the global oral cancer
diagnostics market. However, the process can be quite costly, which can deter
the market growth in the coming years.
Competitive Landscape:
There are several companies in the global
oral cancer diagnostics market that are taking significant steps to solidify
their market position and better the growth rate of the market as a whole.
These companies are Thermo Fisher Scientific Inc. (US), GE Healthcare (US), F.
Hoffmann-La Roche Ltd (Switzerland), Hitachi Ltd (Japan), Siemens Healthineers
(Germany), Canon Medical Systems Corporation (Japan), PeriRx, LLC (US), QIAGEN
(Germany), Vigilant Biosciences, Inc. (US), and Koninklijke Philips NV (Netherlands).
Segmentation:
Indication, diagnosis type, and end-user
are three definite segments that have been considered well for the global oral
cancer diagnostics market. MRFR’s analysis is directed towards various factors
that can reveal routes for the market and ensure better prospects for
growth.
Based on the indication, the global oral
cancer diagnostics market outlook an be segmented into oral verrucous
carcinoma, mucoepidermoid carcinoma (salivary gland), oral squamous cell
carcinoma, oral cavity lymphomas, and others.
Based on the diagnosis type, the oral
cancer diagnostics market comprises X-ray, endoscopy, biopsy, positron emission
tomography (PET), computed tomography (CT), fluorescence imaging, magnetic
resonance imaging (MRI), ultrasonography, Oral Cancer
test kit and others.
Based on the end-user, the oral cancer
diagnostics market includes hospitals & clinics, research & academic
institutes, and others.
Regional Analysis:
Region-specific analysis of the global oral
cancer diagnostics market is including namely, the Americas, Europe,
Asia-Pacific (APAC), and the Middle East & Africa (MEA). The study of these
four regions are expected to provide ample scope to identify various growth
pockets that can be explored later to increase market profitability.
The Americas has the largest market share
and is expected to continue its dominance in coming years. The growth would
rely heavily on the presence of several key players, better healthcare
infrastructure, hike in technological integration, better reimbursement
policies, and others. Major market to provide traction are the US and Canada.
North America is expected to score better than South America.
Europe is the second largest market and it
shares features with the Americas, especially the regional market of North
America. Regional governments are also known for their investment capacity,
alongside other private investors. Among countries, France, Germany, and the UK
are expected to score well in the coming years.
The APAC market is all set to gain
substantially from the growing inclusion of technologies in emerging economies
that are transforming their healthcare sector to accommodate better
technologies and strategic developments. The region has massive population,
which is recording a high number of oral cancer patients. Countries like India,
China, and others are expected to take this market forward.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
According to the report published by Market Research
Future, the global The Endodontic
Devices market is projected to reach USD 1536.96 Million by 2030 at 4.90%
CAGR during the forecast period 2022-2030.
The central soft pulp of a tooth comprised of blood vessels
and nerves, when infected cause sensation of heat and pain, and swelling,
hence, create discomfort. The prime intention of endodontic surgery, the root
canal, is to keep the tooth intact, but just remove the infected or injured
pulp. The increase in intake of food enriched with fat and starch is
contributing to the surge in number of people suffering from dental malaises.
The urge to maintain the dental setup owing to aesthetic purpose is increasing
the adoption of root canal among people. This is boosting the use of endodontic
devices. MRFR identifies these as factors expected to cast a positive impact on
the global endodontic market growth. However, on the downside, certain factors
like the high cost, the possibility of enamel loss, and risk of abnormal
bleeding and abscess can hinder the endodontic devices market expansion.
Segmental Analysis
The endodontic devices market’s segmental study offers a
comprehensive understanding of the market that assists in the identification of
new growth opportunities to augment the market expansion. The
global endodontic devices market study has been segmented into end user
and product.
On the basis of end user, the endodontic devices market
has been segmented into dental clinics, dental hospitals, laboratories, and
dental academic and research institutes.
On the basis of product, the endodontic devices market
has been segmented into consumables and instruments. The consumables segment
has been classified into endodontic burs, endodontic files and shaper,
irritating solution and lubricants, obturation filling materials, and others.
The instruments segment has been narrowed down to apex locators, endodontic
scalers, machine-assisted obturation systems, handpieces, and endodontic
lasers.
Regional Overview
The demographic progress of the endodontic devices market is
evident from the regional segmental study of the market. Based on region, the
endodontic devices market study has been performed across North America, Latin
America, Asia Pacific, Europe, and the Middle East Asia and Africa.
The North and Latin American endodontic devices market is
expected to be at the forefront over the assessment period. Due to unhealthy
changes in the food habit, a surge in the prevalence of dental disease is
observed. This is the leading factor that is anticipated to fuel the
endodontics devices market in the near future.
The large number of people suffering from dental ailments,
in Europe is boosting the need for proper dental care. This in turn, is
increasing the adoption of root canal treatment and dental products. MRFR
forecasts the European endodontics devices market to follow the lead, and grow
at a rapid pace.
The Asia Pacific endodontic devices market is expected to be
the fastest growing in the coming years. According to the United Nations ESCAP,
the geriatric population in this region, by 2050 is expected to be around 1.3
billion people. This is expected to shoot up the regional market growth curve.
The rapidly proliferating healthcare industry and development of advanced
treatments are other factors bolstering the market growth in this region. The
south-east Asia is anticipated to show a promising growth over the forecast
period owing to the increase in the number of dental malaise cases.
The Middle East Asia and Africa is projected to hold the
least share in global endodontic devices market. Political loopholes,
socio-economic backwardness, low per capita income are responsible for the
lagging market growth in the region. However, increase in the governments
funding, supporting research and developmental activities in the healthcare
industry and developed economies like Kuwait, Dubai, UAE, and others can
stimulate the market growth in the upcoming years.
Key Players
The endodontic
devices market players are Davis Schottlander & Davis Ltd, Hu-Friedy
Mfg. Co., LLC, DiaDent Group International, COLTENE Holding, Kerr Corporation,
Ivoclar Vivadent, Ultradent Products, Septodont, Brasseler USA, Surtex
Instruments Limited, DENTSPLY SIRONA, Danaher Corporation, MICRO-MEGA, and
others.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
The global dental
industry market trends is projected to reach approximately USD 60.37
billion by 2030, at a CAGR of 6.9% from 2022 to 2030. Dentistry, also known as
oral medicine and dental medicine, is a branch of medicine that consists of the
study, diagnosis, prevention, and treatment of diseases, disorders, and
conditions of the oral cavity, normally in the dentition but also the oral mucosa,
and of adjacent and related structures and tissues, mainly in the maxillofacial
area. Though primarily associated with teeth among the general public, the
field of dentistry or dental medicine is not limited to teeth but also includes
other aspects of the craniofacial complex, including the temporomandibular
joint and other supporting anatomical structures, and lymphatic, vascular,
muscular, and nervous systems. The rising healthcare expenditure has boosted
the demand for the dental industry, thereby accelerating market growth. Rising
geriatric population is anticipated to drive the demand for the dental industry
further
Segment Analysis
Global Dental Industry Market based on the product has been
segmented into discipline, consumables, and end user. The global dental
industry market, by discipline, has been segmented into
endodontics, restorative
dentistry, prosthodontics, periodontics, orthodontics, cosmetic
dentistry, oral surgery, maxillofacial surgery. On the basis of
consumables, the market is bifurcated into resin composites, dental
biomaterial, dental aesthetic, endodontic supplies, gingival
retraction material, whitening material, denture
adhesive, dental impression, dental burs, dental syringe. On the
basis of end user, the market is bifurcated into hospitals &
clinics, specialty dental centers, and dental academic and research
institutes.
Key Players
MRFR recognizes the following companies as the Key
Players in the global dental industry market— 3M (US), Allergan plc (US),
Coltene Group (Switzerland), Dentsply Sirona (US), and Henry Schein, Inc (US).
Regional Analysis
Global Dental
Industry Market Report, based on region, has been divided into the
Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas has been segmented into North America and Latin
America, with the North America market further divided into the US and Canada.
The Americas dominated the market in 2019 and is likely to continue to command
during the assessment period. This is due to the rising prevalence of dental
disorders, leading to the high demand for dental procedures and a preventive,
restorative, and surgical device for dental care. Additionally, the growing
older population is also helping in the growth of the dental industry market.
According to the Administration for Community Living, the population aged 65
and above increased from 37.2 million in 2006 to 49.2 million in 2016 in the
Americas. Hence, a large patient pool suffering from tooth decay and a rising
geriatric population are expected to boom the market growth in the Americas.
The European dental industry market has been divided into
Western Europe and Eastern Europe. The Western Europe dental industry market
has further been classified into Germany, France, the UK, Italy, Spain, and the
rest of Western Europe. Europe is the second-largest region in the dental
industry as dental and oral diseases are among the major concerns for
Europeans, which ultimately shows the need for better treatment. Hence, the
demand for dental devices is increasing in the EU region, which is augmenting
the growth of the dental device market. The availability of advanced diagnostic
and therapeutic options is also playing an important role in the growth of this
market. Ongoing research by medical research laboratories and academic
institutes is leading to new developments in the effective cure of dental
disorders.
The dental industry market in Asia-Pacific has been
segmented into China, India, Japan, South Korea, Australia, and the rest of
Asia-Pacific. Asia-Pacific is expected to register the highest market growth
potential over the forecast period due to increased government initiative and
the presence of a large number of pharmaceutical companies focused on dental
treatment. The initiatives taken by the government to support the healthcare
system are also fueling the growth of the regional market. For instance, in
August 2020, the government has announced the national health ID for every
Indian to develop a centralized mechanism to identify every participant in the
National Health Stack uniquely. Furthermore, the increasing disposable income
of middle-class families, which accounts for a large population in Asia,
encouraging more spending on health, is driving the growth of the dental
industry market in the region.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
Healthcare
Biometrics Market Share was valued at USD 19.2 billion in 2022. The
Healthcare Biometrics market is projected to grow from USD 23.4816 Billion in
2023 to USD 78.4 billion by 2030, exhibiting a compound annual growth rate
(CAGR) of 22.30% during the forecast period (2023 - 2030). Biometrics has
changed the look and perception of the healthcare domain. Healthcare biometrics
are various biometric applications that are used in clinics and hospitals for
monitoring patient’s health. Healthcare organizations mainly clinical research
organizations, diagnostic laboratories, health insurers, manufacturing
companies and hospitals are its potential users. The healthcare officials these
days are leveraging unique ways to use the biometrics techniques namely iris
scanners, palm vein readers, finger print scanners, facial recognition
solutions amid others. Decrease in inventory theft, control on medical frauds,
safe data recording and integrity of patient identity are the distinct benefits
that biometrics offer. Implementing such emerging technologies are making it
simpler for payers, practices, hospitals and other forms of healthcare
organizations in recognizing individual patients and matching the medical data
of the patient that holds considerable promise.
There are many factors that is fueling the growth of the healthcare
biometrics market. The different market trends and factors in this market
according to an analysis performed by Market Research Future (MRFR) include
increasing healthcare IT application, burgeoning need for cyber security,
increasing biometric development that caters to healthcare facilities, safe
treatment, increasing incidences of medical identity theft and healthcare
fraud, growing population, initiatives taken by the government to support
biometrics implementation in healthcare facilities and improving economic
conditions. On the contrary, factors such as soaring expenditure of biometric
devices coupled with issues associated to the use of this technology may limit
healthcare biometrics market growth.
Regional Analysis
Based on region, the healthcare biometrics market covers
growth opportunities and latest trends across Europe, North America, Asia
Pacific and Rest of the World. Of these, North America will garner a huge
prominence in the market owing to the growing demand for the regulatory
requests and the well-established healthcare domain. Besides, factors such as
the proliferating healthcare insurance industry, extensive use of biometrics in
hospitals and rising digital advancements in the medical technology, significance
of electronic medical records and need for user-friendly software are driving
the growth of the market here. US is the largest contributor as it is backed
with data security, patient monitoring, medical record management, patient
identification and developments in authentic solutions. The healthcare
biometrics market in Europe is highly lucrative and grabs the second position
owing to the increasing need for healthcare biometrics across the region. The
other factors that are contributing to the growth of the market here include
the resurging economy and increased funding. In the APAC region, the healthcare
biometrics market is emerging rapidly with high growth opportunities owing to
the burgeoning healthcare sector, rapidly developing technologies and biometric
models, improving economic conditions and market penetration.
Market Segmentation
In the Market Research Future (MRFR) report, the healthcare
biometrics market Segmentation has been on the basis of technologies,
applications and end-users.
Based on technologies, it is segmented into palm geometry
recognition, iris recognition, behavioral recognition, vein recognition,
fingerprint recognition, face recognition and others. Of these, fingerprint
recognition will have the maximum share in the healthcare biometrics
market.
Based on applications, the healthcare biometrics market is
segmented into data security, medical record management, patient
monitoring, patient identification and others. Of these, medical record
management will have the largest market share.
Based on end users, it is segmented into healthcare
institutes, research laboratories, hospitals and others. Of these, hospitals
will rule the market during the forecast period.
Key Players
Leading players profiled in the healthcare biometrics market
include Imprivata Inc, Integrated Biometrics, Suprema, Inc., Crossmatch
Technologies Inc., Bio-Key International, Inc., NEC Corporation, Morpho (A
Subsidiary of Safran SA), BioEnable Technologies, Fujitsu Limited, and 3M
Cogent Inc.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
E-health services Market Overview by types, by service, by end user, Forecast to
2030. The e-health services are relatively recent
healthcare practices that include incorporation of electronic processes and
communication systems. The rapid adoption of advanced technology in various
sectors is augmenting the utilization of such services all over the world.
Market Research Future (MRFR) has recently
availed a detailed report asserting the E-Health Services Market is projected
to reach USD 8,905 Million by 2030 at 18.50% CAGR during the forecast period
2022-2030.
Market Drivers and Restraints:
The rapid technological development is
playing a crucial role in the expansion of the global e-health services market.
The rise in adoption of advanced technology in the healthcare sector is acting
as a major driver for the expansion of the global e-health services market. The
increasing government initiatives for supporting the use of e-health services
in healthcare sector and emergence of curtailing the escalating healthcare
costs are attributing factors to the growth of the global e-health services
market.
Various regions in the world are facing a
shortage of healthcare professionals and high prevalence of chronic
diseases, leading to the growing need for e-health services in such
regions. The shift in focus of the players of healthcare sector towards
providing patient-centric healthcare facilities is fueling the expansion of the
global e-health services market. The brisk advancement in technology has led to
the increased adoption of cloud computing in the various industrial sectors,
including healthcare, which in turn is driving the global e-health services
market.
The prominent players of the global
e-health services market are IBM Corporation (U.S), Allscripts Healthcare
Solutions Inc. (U.S), GE Healthcare (U.S), McKinsey & Co. (U.S), Motion
Computing Inc. (U.S), Epocrates Inc. (U.S), Telecare Corp. (U.S), Proteus
Digital Health (U.S) Apple (U.S), GE Healthcare (U.S), Boston Scientific Corp
(U.S), and Cerner (U.S).
The benefits of e-health services such as
minimum errors, large data storage and easy access, reliable EHR and
EMR services, secure data sharing, and others are resulting in the
incorporation of e-health services in the healthcare sector, which is driving
the global e-health services market. The global e-health service market is also
observed to be flourishing owing to the increased application of ICT for
clinical and financial data handling in various hospitals and clinics.
On the flipside, the high cost of
installation and maintenance of the services, reluctance towards the adoption
of advanced e-health services among medical professionals, lack of basic
healthcare infrastructure in underdeveloped regions, and privacy and security
concerns among the patients are likely to hamper the growth of the global
e-health service market to some extent.
Market Segmentation:
The global e-health services market has
been segmented on the basis of type, service, and end-users. By type, the
global e-health services market is segmented into electronic health records
(EHR), e-prescribing, telemedicine, big data systems, clinical decision support
system (CDSS), mobile medical technologies, consumer health IT, and knowledge
management system (KMS). By service, the market is segmented into
administrative service, clinical service, and financial service. By end-users,
the market is segmented into hospitals, clinics, health insurance companies and
others.
Detailed Regional Analysis:
The global e-health
services market research report is geographically distributed in for major
regions such as Americas, Europe, Asia-Pacific and the Middle East and Africa.
Among these regions, the North America region is considered to be the largest
market for the e-health services due to the concentration of major players of
global e-health services market in this region, the inclination towards the use
of software for data management and the presence of well-developed healthcare
infrastructure in this region.
The rapid adoption of advanced technology
in the healthcare sector of the Europe region has made it the second largest
market for the e-health services among other regions of the world. Whereas, the
Asia-Pacific region is projecting fastest growth in the global e-health
services market owing to the rapid development and adoption of advanced
technology by healthcare sector in this region.
The e-health services market in the Middle
East and Africa region is projecting steady growth due to lack of technological
awareness and poor healthcare infrastructure in the underdeveloped areas of
this region.
Competitive Analysis:
The increase in research and development
expenditure and focus on strategic mergers and acquisitions by the leading
players of the global e-health services market is strengthening the competition
among the players of the global market.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Downstream
Processing Market trends was valued at USD 21.5 billion in 2022 and is
projected to grow from USD 24.95 Billion in 2023 to USD 61.09 billion by 2030,
exhibiting a compound annual growth rate (CAGR) of 16.09% during the forecast
period (2023 - 2030). Downstream processing refers to the series of operations
required to derive pure and homogeneous protein products from biological
materials such as cells, tissue culture fluid, or plant tissues. There is a
high demand for the end products extracted by downstream processing, owing to
the increasing applicationsin biopharmaceutical products. Thus, the downstream
processing market is anticipated to observe significant growth during the
forecast period.
Many market players are dominating the
global downstream processing market. The prominent players are involved in
strategic agreements,new product launches& developments,joint ventures,
partnerships, collaborations, mergers & acquisitions, geographic
expansionto sustaintheir market positions.For instance, in March 2021, Thermo
Fisher Scientific, Inc. (US) announced that more than USD 600 million would be
invested to expand its bioprocessing production capabilities through 2022 to
meet short-term demands related to COVID-19 as well as long-term efforts to
improve new vaccines and biologics for other conditions.
Key Players
Some of the key players in the global
downstream processing market are Thermo Fisher Scientific Inc. (US), Sartorius
Stedim Biotech S.A. (France), Merck Millipore (Germany), Danaher Corporation
(US), 3M Company (US), Boehringer Ingelheim (Germany), Lonza Group AG
(Switzerland), Eppendorf AG (Switzerland), Corning Incorporated (US), and Asahi
Kasei Corporation (Japan).
Segmentation
The global downstream processing market has
been segmented into technique, product, application, and end user.
By technique, the market has been
segregated into cell disruption, solid-liquid separation,
clarification/concentration, downstream purification techniques, and
formulation. The purification techniques segment is further sub-segmented into
ion exchange, affinity exchange, hydrophobic
interaction, size exclusion chromatography, and others. The purification
techniques segment held a significant share of the market in 2020, as it isone
of the vital steps in downstream processing and has high product
differentiation.
Based on the product, the global downstream
processing market has been classified as chromatography columns &resins,
filters, membrane adsorbers, and others. The chromatography columns
&resinsis one of the most widely used product andwasestimated to bethe
largest segment in 2020.
Based on application, the downstream
processing market is segmented into antibiotic production, hormone production,
antibodies production, vaccine production, and others. Antibiotic productionis
one of the vital applications owing to increasing infectious diseases.
Furthermore, the ongoing pandemic has created a huge demand for vaccine
production globally which further supports the growth of the market.
Based on the end user, the downstream
processing market is segmented into biopharmaceutical manufacturers, contract
manufacturing organizations, and others. The biopharmaceutical manufacturers
segment held the largest market share in 2020 due to increased R&D
activities and production of biologics at a largescale, along with the rapidly
growing biopharmaceutical industry.
Regional Analysis
By region, North America is anticipated to
dominate the global downstream
processing market report, owing to well-established research organizations
involved in research activities, the presence of a high number of contract
manufacturing organizations (CMOs), and the presence of a largenumber of
pharmaceutical and biopharmaceutical companies. Moreover, the rise in R&D
investments by public and private players in the healthcare sectorfurther
drives the market growth.
On the other hand, the European downstream
processing market is driven by rising R&D expenditure by biopharmaceutical
companies, increasing investments in the R&D sector, and the presence of
key market players. For instance, in November 2019, Thermo Fisher Scientific,
Inc. (US) announced that it is investing nearly USD 24 million in its Scotland
site to expand global bioproduction capabilities with additional large-volume
liquid manufacturing capacity for cell culture media.
Asia-Pacific is anticipated to be the
fastest-growing market in the region over the assessment period due to growing
and improving healthcare infrastructure, the establishment of research
organizations, and increasing investments in biotechnology. In addition,
factors such as the growing investments by key market players and the rapidly
developing pharma and biopharma sector in the region are further driving the
market.For instance, in April 2021, Asahi Kasei Corporation, a solution
provider to the biologics manufacturing industry, expanded its business in
China with the launch of Asahi Kasei Bioprocess (Shanghai) Co., Ltd (AKBC).The
launch of AKBC facilitates business expansion in China by localizing inventory
management and order processing for shorter delivery times.
Furthermore, the growth of the market in
theRest of the World is attributed to the booming biotechnology sector and
advancements in chromatographic techniques inthe region.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
The anticoagulation market trends is expected to cross USD
20.54 Billion by 2030 at a CAGR of 7.50% during the forecast period. The global
Anticoagulation
Market is growing steadily due to the rising demand for anticoagulants,
which creates lucrative growth opportunities for the number of players coming
forward with new and better products. The value chain analysis of the market
comprises four major components: research & development and designing,
manufacturing the products, distribution & sales, and post-sales services.
Research &development start with conceptualizing,
followed by design, then development, and lastly, testing. The R&D segment
comprises 25-30% of the value chain. After the product designs are final, the
manufacturing of the product starts. Manufacturing consists of 45-50% of the
value chain. Then comes distribution and sales, which is essential for any
industry.
Key Players
Anticoagulation Market Players are Pfizer Inc (US), Sanofi
(France), Novartis AG (Switzerland), GlaxoSmithKline plc (UK), Daiichi Sankyo
Company, Limited, Inc. (Japan), Johnson & Johnson Services Inc (US),
Boehringer Ingelheim International GmbH (Germany), Bristol-Myers Squibb Company
(US), F. Hoffmann-La Roche Ltd (Switzerland), and Portola Pharmaceuticals, Inc
(US).
Market Segmentation
The global anticoagulation market is segmented into drug
class, route of administration, disease indication, distribution channel, and
region. The drug class segment has been further segmented into direct oral
anticoagulants (DOACs), warfarin, vitamin K, and heparins & Low Molecular
Weight Heparin (LMWH). The disease indication segment is further segmented into
heart attacks, stroke, Deep Vein Thrombosis (DVT)/Pulmonary Embolism (PE),
Mechanical Heart Valves (MHV), and others. The route of administration segment
has been further segmented into oral, injectable, andothers. The distribution
channel segment is segmented into retail pharmacies, hospital pharmacies,
andonline pharmacies.
Regional Analysis
The global anticoagulation market, based on region, has been
divided into North America, Europe, Asia-Pacific, and the Rest of the World.
The North American market accounted for the largest share in
2019 and is expected to increase at a CAGR of 8.20% during the forecast period.
This is due to the rising prevalence of venous thromboembolism (VTE) and
cardiovascular disorders, increased risk of a blood clot in various medical
conditions, and the adoption of NOACs globally. According to a published
article in PubMed in 2019, NOACs have emerged as promising alternatives to
Vitamin K Antagonists (VKAs). However, there are some considerations and challenges
to their introduction in developing countries.
Europe accounted for a market size of USD 5,205.37million in
2019 and is expected to grow at a CAGR of 7.26% during the forecast period. It
has evolved as a prominent market with increased cardiovascular diseases and
rising investments in R&D in the pharmaceutical sector. The region has
considerable growth potentials that would help expand the global market in the
coming years. However, stringent regulations set by various governments are
hampering the market growth in the European region.
The anticoagulation market research Report in Asia-Pacific
has been segmented into China, India, Japan, South Korea, Australia, and the
Rest of Asia-Pacific. Asia-Pacific is expected to showthe highest growth rate
during the forecast period from 2020 to 2027. Factors such as an increasing patient
population suffering from various chronic and acute diseases, rising prevalence
of cardiovascular disease and VTE, developing economies, improving diagnosis
rate, and growing demand for ideal therapeutics are anticipated to boost the
market growth. Furthermore, continuous economic development with evolving
healthcare infrastructure and improving healthcare awareness have further
supported the market's growth. However, increasing treatment expenditure for
anticoagulant drugs is anticipated to hamper the market growth in the
Asia-Pacific region.
About Market Research
Future:
At Market Research
Future (MRFR), we enable our customers to unravel the complexity of various
industries through our Cooked Research Report (CRR), Half-Cooked Research
Reports (HCRR), & Consulting Services. MRFR team have supreme objective to
provide the optimum quality market research and intelligence services to our
clients.
According to MRFR analysis, The Cell
Counting Market size is expected to cross USD 14.56 Billion by 2030 at a
CAGR of 7.8% during the forecast period 2022-2030.
Cell counting is important for research and serves as one of
the major steps in the majority of experiments. It is effectively utilized for
maintaining cell cultures. Moreover, another important application of cell
counting can be seen in the diagnosis of chronic diseases like cancer. For
instance, an increase in the number of white blood cells (WBC) may indicate the
possibility of cancerous growth in the body. Thus, cell counting is important
for microbiology, hematology and other medical specialties.
The growth of the global cell counting market is determined
by numerous factors such as increasing R&D expenditure, rising prevalence
of cancer, and product launches. However, the high cost of devices and product
recalls are projected to restrain the growth of the market during the forecast
period.
The Global Cell Counting Market is currently dominated by
several market players. The key players are involved in product launches,
expansion, and strategic collaborations to strengthen their market positions.
Recently in April 2019, the Nexcelom Bioscience LLC launched Cellaca MX
automated cell counter.
Regional Analysis
The market has been divided, by region, into the Americas,
Europe, Asia-Pacific, and the Middle East & Africa.
The Americas is anticipated to hold the largest market share
owing to the increase in the incidence of cancer and the presence of
well-established pharmaceutical and biotechnology industry. The cell counting
market in the Americas has further been branched into North America and Latin
America, with the North American market divided into the US and Canada.
The European cell counting market has been categorized as
Western Europe and Eastern Europe. The Western European market has further been
classified as Germany, France, the UK, Italy, Spain, and the rest of Western
Europe. The cell counting market in Asia-Pacific has been segmented into Japan,
China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the
presence of a large patient pool and expansion of healthcare facilities, the
market in Asia-Pacific is expected to be the fastest-growing. The cell counting
market in the Middle East & Africa has been divided into the Middle East
and Africa.
Segmentation
The Global Cell
Counting Market Insights has been segmented based on product, application,
and end-user.
The market, based on type, has been divided into consumables
and instruments. The consumable segment is likely to hold maximum
market share in the global cell counting market. This due to the repeated
purchase of the consumable compared with instrument products.
The global cell counting market based
on application has been segregated into research application,
clinical & diagnostic application, and others. The research application
segment is anticipated to hold the largest share in the market due to the
rising funding for stem cell research.
The end-user segments of the market are
pharmaceutical and biotechnology companies, hospitals, research institutes, and
others. The pharmaceutical and biotechnology companies’ segment is expected to
hold the largest share of the market, as these are used cell counting products
in research and development of new drugs and therapies.
Key Players
Some of the Key Players in the Global Cell Counting
Market are Thermo Fisher Scientific (US), Merck KGaA (Germany),
Danaher Corporation (US), Bio-Rad Laboratories, Inc. (US), Logos Biosystems,
Inc. (South Korea), Olympus Corporation (Japan), Agilent Technologies, Inc.
(US), PerkinElmer, Inc. (US), Sysmex Corporation (Japan), Abbott Laboratories
(US), and others.
Preimplantation Genetic Testing
Market Overview and
Analysis by Procedure, Type, Application, Technology and forecast to 2030. It is estimated that the global preimplantation genetic testing
market is grow USD 545.8 Million in 2030 and is projected to register a CAGR of
around 10.20% over the forecast period 2022-2030.
Preimplantation genetic testing is the
testing at the pre-implantation stage for detection of genetic defects in
embryos or oocytes. Preimplantation genetic testing has occurred more
frequently in recent years in North America and Europe, due to the advancement
in genetic technology.
The decreasing fertility rates worldwide
enhance the acceptance of the preimplantation genetic testing to avoid further
complications of chromosomal abnormalities with advancing maternal age. This
leads to the growth of the genetic testing for rare diseases during the
forecast period. According to the Vital Statistics Rapid Release, the total
fertility rate for the US in 2017 was 1,764.5 births per 1,000 women, and in
2016 it was 1,820.5, which is 3% less, this shows the reduction in the
rate of fertility.
An increasing number of fertility clinics
worldwide, new development technological advancements in the field of genetic
analysis and high threat of chromosomal abnormalities with advancing
maternal age are the other driving factors for global preimplantation genetic
testing market
Key Players
Some of the major players in the global
preimplantation genetic testing market are Natera, Inc.CooperSurgical, Inc., F.
Hoffmann-La Roche AG, Illumina, Inc., IGENOMIX, Reprogenetics, LLC, Genea
Limited, PerkinElmer, Inc., Genesis Genetics Ltd., Quest Diagnostics
Incorporated, Thermo FisherScientific, Inc, Bioarrayn Genetics, Laboratory
Corporation of America Holdings, California Pacific Medical Center and
Reproductive Health Science Ltd
Segmentation
The global preimplantation genetic testing
market is segmented based on procedure, type, application, technology, product
and service, end user, and region.
The global market for preimplantation
genetic testing, by procedure, is segmented into preimplantation genetic
diagnosis (PGD) and preimplantation genetic screening (PGS). Hundred different
genetic conditions can be tested with Preimplantation Genetic Diagnosis (PGD)
which enables the couple to have a baby with no genetic defect thus the segment
is expected to hold the largest market share owing to rising awareness
population and healthcare experts. Preimplantation Genetic Screening (PGS)
segment is also anticipated to grow profitably to increase healthy pregnancy.
By type, embryo testing segment is expected
to show favorable growth as the threat of chromosomal abnormalities increases.
By product and service, the reagents and consumables segment anticipated to
hold the largest market share as there is continuous declination infertility of
female due to increasing usage of reagents for the diagnosis. By technology,
the next-generation
sequencing segment, and comparative genomic hybridization also expected to
hold large share as its cost is reduced and its capability to detect mosaicism.
The market by end user has been segmented into maternity centers &
fertility clinics
hospitals, diagnostic labs and research
laboratories & academic institutes. Based on region, the global
preimplantation genetic testing market is segmented into the Americas, Europe,
Asia-Pacific, and the Middle East and Africa.
Regional Analysis
The market has been divided, by region,
into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The
global preimplantation
genetic testing market research report in the Americas has further been
branched into North America and Latin America, with the North American market
divided into the US and Canada. The European global preimplantation genetic
testing market has been sub-divided Western Europe and Eastern Europe. Western
Europe has further been classified as Germany, France, UK, Italy, Spain, and
the rest of Western Europe. The global preimplantation genetic testing market
in Asia-Pacific has been segmented into Japan, China, India, South Korea,
Australia, and the rest of Asia-Pacific. The IPF treatment market in the Middle
East & Africa has been divided into the Middle East and Africa.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
The minimally-invasive
surgery devices market trends is expected to reach USD 26165.04 Million by
2030 at 9.20% CAGR during the forecast period 2022-2030. The minimally invasive
surgery devices market is gaining traction due to increasing geriatric
population and increasing prevalence life-threating and chronic diseases. The
minimally invasive surgeries are less traumatic and comparatively safer, which
makes the healing process faster and less painful. As per the World Health
Organization (WHO), the prevalence of chronic diseases is estimated to escalate
by 60% by the end of 2020 and 79% of the deaths are caused due to these
diseases especially in developing countries.
These surgeries are increasingly evolving in the field of
ophthalmic, orthopedic, cardiac, oral surgical, and neurological procedures.
Thanks to the continuous advancements in the surgical procedures makes it the
more efficient and accurate, which boosts their adoption substantially.
Additionally, increasing awareness about benefits of the
minimally invasive procedures is creating demand and is estimated to remain
same in coming years. Further, rising popularity of robotic and non-robotic
minimally invasive surgeries are fueling growth of the global minimally
invasive surgery devices market.
Increasing inclination toward the personal aesthetics, the
demand for cosmetics and plastic surgeries are boosting adoption of minimally
invasive surgeries, which in turn drives the growth of the minimally invasive
surgery devices market. As per reports by the American Society of Plastic
Surgeons, around 15.4 million cosmetic procedures were performed with minimally
invasive surgical procedures in 2016. However, stringent government regulations
coupled with high cost of surgery devices are restraining market growth.
Nonetheless, the cost of these procedures is less than conventional surgeries
which are likely to offer most lucrative opportunities for growth in coming
years.
Competitive Analysis:
Some of the key players operating in the global minimally
invasive surgery devices market are Abbott, Medtronic, Inc, GE Healthcare,
Ethicon, Inc., Siemens Healthcare GmbH, Intuitive Surgical, Inc, ArthroCare
Corporation, NuVasive, Inc., DePuy Synthes, Biomet, Inc, KEBOMED Europe AG,
Norwood Medical, Fortimedix Surgical, and Freudenberg Medical.
Segmentation:
The minimally
invasive surgery devices market report is segmented based on type,
application, end-user, and region.
In terms of type, the global minimally invasive surgery
devices market is categorized into handheld instruments, cutter instruments,
inflation devices, guiding devices, auxiliary devices, electrosurgical devices,
and others.
In terms of application, the minimally invasive surgery
devices market is segmented into cardiac surgery, orthopedic surgery,
gastrointestinal surgery, vascular surgery, urological surgery, gynecological
surgery, thoracic surgery, dental surgery, cosmetic
surgery, and others.
In terms of end-user, the minimally invasive surgery devices
market is segmented into ambulatory surgical centers, hospitals & clinics,
and others.
As per the region, the minimally invasive surgery devices
market is segmented into Americas, Asia-Pacific, Europe, and the Middle East
& Africa.
Regional Analysis:
Regionally, the Americas is estimated to dominate the global
minimally invasive surgery devices market owing to large patient pool, high
healthcare investment, and well-developed infrastructure. Additionally, growing
government funding backing for adoption of advanced healthcare facilities for
the several life-threating diseases are benefiting growth of the global
minimally invasive surgery market. The market in Europe is estimated to secure
second leading position in terms of revenue.
However, Asia Pacific is predicted to expand at a highest
CAGR in coming future due to substantial rise in patient pool, presence of
large population, growth in government investments. Rise in geriatric
population which is prone for several diseases which creates need for
development of better facilities in the region. Additionally, emerging
economies in the region are investing more for improvement in healthcare
infrastructure and adoption of advanced surgical devices.
About US:
Market Research Future (MRFR), enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.